Common diagnostic challenges in the pathology of nonneoplastic lung diseases: A case-based review

Archives of Pathology and Laboratory Medicine

Volumn 133, Issue 11, 2009, Pages 1782-1792

  Lagstein, Amir ^a   Myers, Jeffrey L ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPIRATION PNEUMONIA; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; HISTIOCYTOSIS X; HUMAN; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; LUNG DISEASE; RADIODIAGNOSIS; WEGENER GRANULOMATOSIS;

AGED; BIOPSY; FEMALE; GIANT CELLS, FOREIGN-BODY; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; MALE; PNEUMONIA, ASPIRATION; RESPIRATORY FUNCTION TESTS; WEGENER GRANULOMATOSIS;

EID: 70449394023     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (56)

1. American Thoracic Society/European Respiratory Society International. Multidisciplinary consensus classification of the idiopathic interstitial pneumonias [published correction appears in Am J Respir Crit Care Med. 2002; 166(3):426]. Am J Respir Crit Care Med. 2002;165(2):277-304.
2. Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med. 1998;157(4):1301-1315. (Pubitemid 28225203)
3. Myers J. Idiopathic Interstitial pneumonias. In: Churg A, Myers J, Tazelaar HD, Wright JL, eds. Thurlbeck's Pathology of the Lung. New York, NY: Thieme; 2004:563-600.
4. Nadrous HF, Myers JL, Decker PA, Ryu JH. Idiopathic pulmonary fibrosis in patients younger than 50 years. Mayo Clin Proc. 2005;80(1):37-40. (Pubitemid 40075989)
5. Collard HR, Moore BB, Flaherty KR, et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2007;176(7):636-643. (Pubitemid 47503070)
6. Martinez FJ, Safrin S, Weycker D, et al. The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med. 2005;142(12):963-967. (Pubitemid 40840310)
7. Parambil JG, Myers JL, Ryu JH. Histopathologic features and outcome of patients with acute exacerbation of idiopathic pulmonary fibrosis undergoing surgical lung biopsy. Chest. 2005;128(5):3310-3315.
8. Johkoh T, Muller NL, Cartier Y, et al. Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients. Radiology. 1999;211(2): 555-560. (Pubitemid 29206830)
9. Sumikawa H, Johkoh T, Ichikado K, et al. Usual interstitial pneumonia and chronic idiopathic interstitial pneumonia: analysis of CT appearance in 92 patients. Radiology. 2006;241(1):258-266. (Pubitemid 44437504)
10. Flaherty KR, Thwaite EL, Kazerooni EA, et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax. 2003; 58(2):143-148.
11. Sumikawa H, Johkoh T, Colby TV, et al. Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival. Am J Respir Crit Care Med. 2008;177(4):433-439. (Pubitemid 351317587)
12. Myers J, Katzenstein AL. Beyond a consensus classification for idiopathic interstitial pneumonias: progress and controversies. Histopathology. 2009;54(1): 90-103.
13. Katzenstein AL, Mukhopadhyay S, Myers JL. Diagnosis of usual interstitial pneumonia and distinction from other fibrosing interstitial lung diseases. Hum Pathol. 2008;39(9):1275-1294.
14. Katzenstein AL, Zisman DA, Litzky LA, Nguyen BT, Kotloff RM. Usual interstitial pneumonia: histologic study of biopsy and explant specimens. Am J Surg Pathol. 2002;26(12):1567-1577.
15. Allen TC. Pulmonary Langerhans cell histiocytosis and other pulmonary histiocytic diseases: a review. Arch Pathol Lab Med. 2008;132(7):1171-1181. (Pubitemid 351955744)
16. Lieberman PH, Jones CR, Steinman RM, et al. Langerhans cell (eosinophilic) granulomatosis: a clinicopathologic study encompassing 50 years. Am J Surg Pathol. 1996;20(5):519-552.
17. Travis WD, Borok Z, Roum JH, et al. Pulmonary Langerhans cell granulomatosis (histiocytosis X): a clinicopathologic study of 48 cases. Am J Surg Pathol. 1993;17(10):971-986. (Pubitemid 23289339)
18. Vassallo R, Ryu J, Colby T, Hartman T, Limper A. Pulmonary Langerhans'- cell histiocytosis. N Engl J Med. 2000;342(26):1969-1978.
19. Sundar KM, Gosselin MV, Chung HL, Cahill BC. Pulmonary Langerhans cell histiocytosis: emerging concepts in pathobiology, radiology, and clinical evolution of disease. Chest. 2003;123(5):1673-1683.
20. Fartoukh M, Humbert M, Capron F, et al. Severe pulmonary hypertension in histiocytosis X. Am J Respir Crit Care Med. 2000;161(1):216-223.
21. Delobbe A, Durieu J, Duhamel A, Wallaert B. Determinants of survival in pulmonary Langerhans' cell granulomatosis (histiocytosis X). Eur Respir J. 1996; 9(10):2002-2006. (Pubitemid 26333534)
22. Vassallo R, Ryu J, Schroeder D, Decker P, Limper A. Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults. N Engl J Med. 2002;346(7): 484-490. (Pubitemid 34441739)
23. Brauner MW, Grenier P, Tijani K, Battesti JP, Valeyre D. Pulmonary Langerhans cell histiocytosis: evolution of lesions on CT scans. Radiology. 1997; 204(2):497-502. (Pubitemid 27337502)
24. Primack SL, Hartman TE, Hansell DM, Muller NL. End-stage lung disease: CT findings in 61 patients. Radiology. 1993;189(3):681-686. (Pubitemid 23354476)
25. Myers J. Other diffuse lung diseases. In: Churg A, Myers J, Tazelaar HD, Wright JL, eds. Thurlbeck's Pathology of the Lung. 3rd ed. New York, NY: Theime; 2004:608-614.
26. Lau SK, Chu PG, Weiss LM. Immunohistochemical expression of langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders. Am J Surg Pathol. 2008;32(4):615-619.
27. Sholl LM, Hornick JL, Pinkus JL, Pinkus GS, Padera RF. Immunohistochemical analysis of langerin in Langerhans cell histiocytosis and pulmonary inflammatory and infectious diseases. Am J Surg Pathol. 2007;31(6):947-952.
28. Vassallo R, Jensen E, Colby T, et al. The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis. Chest. 2003;124(4):1199-1205.
29. Kambouchner M, Basset F, Marchal J, Uhl J, Hance A, Soler P. Threedimensional characterization of pathologic lesions in pulmonary Langerhans cell histiocytosis. Am J Respir Crit Care Med. 2002;166(11):1483-1490. (Pubitemid 35387299)
30. Soler P, Bergeron A, Kambouchner M, et al. Is high-resolution computed tomography a reliable tool to predict the histopathological activity of pulmonary Langerhans cell histiocytosis? Am J Respir Crit Care Med. 2000;162(1):264-270.
31. Bynum LJ, Pierce AK. Pulmonary aspiration of gastric contents. Am Rev Respir Dis. 1976;114(6):1129-1136.
32. Landay MJ, Christensen EE, Bynum LJ. Pulmonary manifestations of acute aspiration of gastric contents. AJR Am J Roentgenol. 1978;131(4):587-592. (Pubitemid 9021980)
33. Barnes TW, Vassallo R, Tazelaar HD, Hartman TE, Ryu JH. Diffuse bronchiolar disease due to chronic occult aspiration. Mayo Clin Proc. 2006; 81(2):172-176. (Pubitemid 43205769)
34. Mukhopadhyay S, Katzenstein AL. Pulmonary disease due to aspiration of food and other particulate matter: a clinicopathologic study of 59 cases diagnosed on biopsy or resection specimens. Am J Surg Pathol. 2007;31(5): 752-759. (Pubitemid 46684216)
35. Fraser R. Protozoal and helminthic pulmonary disease. In: Churg A, Myers J, Tazelaar HD, Wright JL, eds. Thurlbeck's Pathology of the Lung. 3rd ed. New York, NY: Thieme; 2004:315-329.
36. Cordier JF, Valeyre D, Guillevin L, Loire R, Brechot JM. Pulmonary Wegener's granulomatosis: a clinical and imaging study of 77 cases. Chest. 1990; 97(4):906-912. (Pubitemid 20132316)
37. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992;116(6):488-498.
38. Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med. 1997;337(21): 1512-1523.
39. Stone JH; Wegener's Granulomatosis Etanercept Trial Research Group. Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial. Arthritis Rheum. 2003;48(8):2299-2309.
40. Bligny D, Mahr A, Toumelin PL, Mouthon L, Guillevin L. Predicting mortality in systemic Wegener's granulomatosis: a survival analysis based on 93 patients. Arthritis Rheum. 2004;51(1):83-91. (Pubitemid 38222287)
41. Seo P, Specks U, Keogh KA. Efficacy of rituximab in limited Wegener's granulomatosis with refractory granulomatous manifestations. J Rheumatol. 2008;35(10):2017-2023.
42. Lee AS, Wiesner O, Gillespie DJ, Witzig TE, Homburger H, Specks U. A 70-year-old man with pulmonary infiltrates and a positive antineutrophil cytoplasmic autoantibody test result. Chest. 2005;127(3):1045-1050. (Pubitemid 40775539)
43. Stone JH, Talor M, Stebbing J, et al. Test characteristics of immunofluorescence and ELISA tests in 856 consecutive patients with possible ANCAassociated conditions. Arthritis Care Res. 2000;13(6):424-434. (Pubitemid 32003389)
44. Hoffman GS, Specks U. Antineutrophil cytoplasmic antibodies. Arthritis Rheum. 1998;41(9):1521-1537.
45. Savige J, Dimech W, Fritzler M, et al; International Group for Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA). Addendum to the International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies: quality control guidelines, comments, and recommendations for testing in other autoimmune diseases. Am J Clin Pathol. 2003;120(3):312-318.
46. Savige J, Gillis D, Benson E, et al. International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA). Am J Clin Pathol. 1999;111(4):507-513. (Pubitemid 29153147)
47. Vassilopoulos D, Niles JL, Villa-Forte A, et al. Prevalence of antineutrophil cytoplasmic antibodies in patients with various pulmonary diseases or multiorgan dysfunction. Arthritis Rheum. 2003;49(2):151-155. (Pubitemid 36418271)
48. Jennette JC, Falk RJ. New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies. Curr Opin Rheumatol. 2008;20(1):55-60.
49. Sheehan RE, Flint JD, Müller NL. Computed tomography features of the thoracic manifestations of Wegener granulomatosis. J Thorac Imaging. 2003; 18(1):34-41.
50. Katzenstein AL, Locke WK. Solitary lung lesions in Wegener's granulomatosis: pathologic findings and clinical significance in 25 cases. Am J Surg Pathol. 1995;19(5):545-552.
51. Travis WD, Hoffman GS, Leavitt RY, Pass HI, Fauci AS. Surgical pathology of the lung in Wegener's granulomatosis: review of 87 open lung biopsies from 67 patients. Am J Surg Pathol. 1991;15(4):315-333.
52. Yousem SA, Lombard CM. The eosinophilic variant of Wegener's granulomatosis. Hum Pathol. 1988;19(6):682-688.
53. Yousem SA. Bronchocentric injury in Wegener's granulomatosis: a report of five cases. Hum Pathol. 1991;22(6):535-540.
54. Uner AH, Rozum-Slota B, Katzenstein AL. Bronchiolitis obliterans- organizing pneumonia (BOOP)-like variant of Wegener's granulomatosis: a clinicopathologic study of 16 cases. Am J Surg Pathol. 1996;20(17):794-801. (Pubitemid 26230742)
55. Myers JL, Katzenstein AL. Wegener's granulomatosis presenting with massive pulmonary hemorrhage and capillaritis. Am J Surg Pathol. 1987(11);11: 895-898. (Pubitemid 18003399)
56. Green RJ, Ruoss SJ, Kraft SA, Duncan SR, Berry GJ, Raffin TA. Pulmonary capillaritis and alveolar hemorrhage. Update on diagnosis and management. Chest. 1996;110(5):1305-1316.